Remission in Cushing disease with cabergoline.
Gopal
Raju
R
Bandgar
Tushar
T
Menon
Padma
P
Shah
Nalini
N
D000236:Adenoma / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D002648:Child; D003480:Cushing Syndrome / Q000097:blood / Q000209:etiology*; D018450:Disease Progression; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D012074:Remission Induction; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D004873:Ergolines; D000324:Adrenocorticotropic Hormone; D000077465:Cabergoline